• Citer

Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Effect of ceruletide in schizophrenia

par Lotstra, Françoise ;Verbanck, Paul ;Gilles, Christian;Mendlewicz, Julien ;Vanderhaeghen, Jean-Jacques
Référence Annals of the New York Academy of Sciences, 448, page (507-517)
Publication Publié, 1985-07

Article révisé par les pairs

• Détails
• Contenu

Titre:	Reduced cholecystokinin levels in cerebrospinal fluid of parkinsonian and schizophrenic patients. Effect of ceruletide in schizophrenia
Auteur:	Lotstra, Françoise; Verbanck, Paul; Gilles, Christian; Mendlewicz, Julien; Vanderhaeghen, Jean-Jacques
Informations sur la publication:	Annals of the New York Academy of Sciences, 448, page (507-517)
Statut de publication:	Publié, 1985-07
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adult
	Aged
	Caerulein -- therapeutic use
	Cholecystokinin -- cerebrospinal fluid
	Clinical Trials as Topic
	Dopamine -- secretion
	Double-Blind Method
	Female
	Humans
	Male
	Middle Aged
	Parkinson Disease -- cerebrospinal fluid
	Schizophrenia -- cerebrospinal fluid
	Schizophrenia -- drug therapy
Note publication spéciale:	Neuronal Cholecystokinin
Note générale:	Clinical Trial
	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: NotDefined.j
	FLWNA
Langue:	Anglais
Identificateurs:	urn:issn:0077-8923
	info:doi/10.1111/j.1749-6632.1985.tb29944.x
	info:scp/0022271315
	info:pmid/3896098
	VX-025578